Flagship Harbor Advisors, LLC Invitae Corp Transaction History

Flagship Harbor Advisors, LLC

  • $1.74 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$39.09 - $57.4 $23,454 - $34,440
-600 Closed
0 $0
Q3 2020

Oct 13, 2020
BUY
$28.43 - $44.67 $8,529 - $13,401
300 Added 100.0%
600 $26,000
Q2 2020

Jul 31, 2020
BUY
$11.71 - $30.29 $2,342 - $6,058
200 Added 200.0%
300 $9,000
Q1 2020

May 12, 2020
BUY
$7.64 - $27.5 $764 - $2,750
100 New
100 $1,000

Others Institutions Holding NVTA

# of Institutions
21
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email